|
1
|
Vervoorts J, Lüscher-Firzlaff J and
Lüscher B: The ins and outs of MYC regulation by posttranslational
mechanisms. J Biol Chem. 281:34725–34729. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou RH, Kokame K, Tsukamoto Y, Yutani C,
Kato H and Miyata T: Characterization of the human NDRG gene
family: a newly identified member, NDRG4, is specifically expressed
in brain and heart. Genomics. 73:86–97. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y
and He F: Characterization and expression of three novel
differentiation-related genes belong to the human NDRG gene family.
Mol Cell Biochem. 229:35–44. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lusis EA, Watson MA, Chicoine MR, Lyman M,
Roerig P, Reifenberger G, Gutmann DH and Perry A: Integrative
genomic analysis identifies NDRG2 as a candidate tumor suppressor
gene frequently inactivated in clinically aggressive meningioma.
Cancer Res. 65:7121–7126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lorentzen A, Vogel LK, Lewinsky RH, et al:
Expression of NDRG2 is down-regulated in high-risk adenomas and
colorectal carcinoma. BMC Cancer. 7:1922007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu N, Wang L, Liu X, et al: Promoter
methylation, mutation, and genomic deletion are involved in the
decreased NDRG2 expression levels in several cancer cell lines.
Biochem Biophys Res Commun. 358:164–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu N, Wang L, Li X, et al: N-Myc
downstream-regulated gene 2 is involved in p53-mediated apoptosis.
Nucleic Acids Res. 36:5335–5349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma J, Jin H, Wang H, Yuan J, Bao T, Jiang
X, Zhang W, Zhao H and Yao L: Expression of NDRG2 in clear cell
renal cell carcinoma. Biol Pharm Bull. 31:1316–1320. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang ZL, Kang K, Yoon S, Huang SM, Lim
JS, Kim JM, Lim JS and Lee HJ: NDRG2 is involved in the oncogenic
properties of renal cell carcinoma and its loss is a novel
independent poor prognostic factor after nephrectomy. Ann Surg
Oncol. 19:2763–2012. PubMed/NCBI
|
|
11
|
Zheng J, Li Y, Yang J, et al: NDRG2
inhibits hepatocellular carcinoma adhesion, migration and invasion
by regulating CD24 expression. BMC Cancer. 251:1–9. 2011.
|
|
12
|
Kim YJ, Yoon SY, Kim JT, Choi SC, Lim JS,
Kim JH, Song EY, Lee HG, Choi I and Kim JW: NDRG2 suppresses cell
proliferation through down-regulation of AP-1 activity in human
colon carcinoma cells. Int J Cancer. 124:7–15. 2009. View Article : Google Scholar
|
|
13
|
Ma JJ, Liao CG, Jiang X, Zhao HD, Yao LB
and Bao TY: NDRG2 suppresses the proliferation of clear cell renal
cell carcinoma cell A-498. J Exp Clin Cancer Res. 29:1032010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Majno G and Joris I: Apoptosis, oncosis,
and necrosis. An overview of cell death. Am J Pathol. 146:3–15.
1995.PubMed/NCBI
|
|
15
|
Trump BF, Berezesky IK, Chang SH and
Phelps PC: The pathways of cell death: oncosis, apoptosis, and
necrosis. Toxicol Pathol. 25:82–88. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Gong L, Li X, Ye L, Wang B, Liu J,
Qiu J, Jiao H, Zhang W, Chen J and Wang J: Infrasound increases
intracellular calcium concentration and induces apoptosis in
hipocampi of adult rats. Mol Med Rep. 5:73–77. 2012.
|
|
17
|
Chanan-Khan A, Srinivasan S and Czuczman
MS: Prevention and management of cardiotoxicity from antineoplastic
therapy. J Support Oncol. 2:251–256; discussion 259–261, 264–266.
2004.PubMed/NCBI
|
|
18
|
Duan J, Lang Y, Song C, Xiong J, Wang Y
and Yan Y: siRNA targeting of PRDX3 enhances cisplatin-induced
apoptosis in ovarian cancer cells through the suppression of the
NF-κb signaling pathway. Mol Med Rep. 7:1688–1694. 2013.PubMed/NCBI
|
|
19
|
Zhu J, Okumura H, Ohtake S, Nakamura S and
Nakao S: The molecular mechanism of arsenic trioxide-induced
apoptosis and oncosis in leukemia/lymphoma cell lines. Acta
Haematol. 110:1–10. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whelan RS, Kaplinskiy V and Kitsis RN:
Cell death in the pathogenesis of heart disease: mechanisms and
significance. Annu Rev Physiol. 72:19–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boulkroun S, Fay M, Zennaro MC, Escoubet
B, Jaisser F, Blot-Chabaud M, Farman N and Courtois-Coutry N:
Characterization of rat NDRG2 (N-Myc downstream regulated gene 2),
a novel early mineralocorticoid-specific induced gene. J Biol Chem.
277:31506–31515. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L, Liu N, Yao L, et al: NDRG2 is a
new HIF-1 target gene necessary for hypoxia-induced apoptosis in
A549 cells. Cell Physiol Biochem. 21:239–250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu D, Wang Q, An Y and Xu L: MiR-203
regulates the proliferation, apoptosis and cell cycle progression
of pancreatic cancer cells by targeting Survivin. Mol Med Rep.
8:379–384. 2013.PubMed/NCBI
|
|
24
|
Park Y, Shon SK, Kim A, Kim KI, Yang Y,
Cho DH, Lee MS and Lim JS: SOCS1 induced by NDRG2 expression
negatively regulates STAT3 activation in breast cancer cells.
Biochem Biophys Res Commun. 363:361–367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mills EM, Xu D, Fergusson MM, Combs CA, Xu
Y and Finkel T: Regulation of cellular oncosis by uncoupling
protein 2. J Biol Chem. 277:27385–27392. 2002. View Article : Google Scholar : PubMed/NCBI
|
